A bill was recently presented to the Costa Rican Congress proposing a reform to the Patent Law in order to limit patentability of genetic material.
The proposed bill intended to exclude from patentability "inventions related to organs, human tissue, human cells and their parts, as well as DNA sequences and any human genetic material".
Even though the intention was to limit patentability of human genes and the human genome because of ethical and moral questions the reform, poorly drafted as it was, could have been interpreted as to limit the protection of intellectual property rights on biotechnological inventions, risking as well research and development of innovative diagnostic, therapeutic, agricultural and environmental products.
Interested parties like the patent sector and biotechnology industry were all against the proposed legislation, therefore asked for the bill to be removed from the congress floor.
Fortunately, and as a result, the bill is no longer on the legislative for debate.